| رمز التصنيف العلاجي الصيدلاني (ATC) | الإسم | ب / ج | المكونات | الجرعة | الشكل | السعر |
|---|---|---|---|---|---|---|
| J07BC01 | ENGERIX-B 20 | B | Hepatitis B, purified antigen - 20mcg/ml | 20mcg/ml | Injectable suspension | 1652926.275 |
| J07BC01 | ENGERIX-B 10 | B | Hepatitis B, surface antigen - 10mcg/0.5ml | 10mcg/0.5ml | Injectable suspension | 1042821.78 |
| J07BC01 | HEPATITIS-B VACCINE (r DNA) PAEDIATRIC | G | Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.25mg to 0.40mg) - 10mcg/0.5ml | 10mcg/0.5ml | Injectable suspension | 646388.2425 |
| J07BB02 | INFLUVAC | B | Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml | Injectable suspension | 573820.7475 | |
| J07BB01 | VAXIGRIP | B | Influenza vaccine virus inactivated - 15mcg/3strains/0.5ml | 15mcg/3strains/0.5ml | Injectable suspension | 768677.91 |
| J07BB01 | INFLUVAC TETRA | B | Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml | Injectable suspension | 970254.285 | |
| J07BB01 | VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE) | B | Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml | Injectable suspension | 970254.285 | |
| J07BB01 | GC FLU QUADRIVALENT INFLUENZA VACCINE | G | Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml | Injectable suspension | 791523.2325 | |
| J07AX | URO-VAXOM | B | Lyophilized bacterial lysates of E-Coli - 6mg | 6mg | Capsule | 2689028.8425 |
| J07AX | BRONCHO-VAXOM CHILDREN | B | Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis - 3.5mg | Capsule | 1988886.9 | |
| J07AX | BRONCHO-VAXOM ADULTS | B | Lyophilized bacterial lysates of Haemophilus influenzae, Diplococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis - 7mg | Capsule | 2746814.07 | |
| J07AP03 | TYPHIM VI | B | Salmonella typhi polysaccharides - 0.025mg/0.5ml | 0.025mg/0.5ml | Injectable solution | 1118076.96 |
| J07AP03 | TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT) | B | Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml | Injectable suspension | 4020776.76 | |
| J07AL02 | PREVENAR 13 | B | Polysaccharide for serotypes 1, 3, 4, 5 , 6A, 7F, 9V,14, 18C, 19A, 19F, 23F (2.2mcg)Polysaccharide for serotypes 6B (4.4mcg)Conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.125mg aluminium) - | Injectable suspension | 6352343.4975 | |
| J07AL02 | SYNFLORIX | B | Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg | Injectable suspension | 4675228.0575 | |
| J07AL02 | PNEUMOSIL (10-VALENT) | G | Pneumococcal polysaccharide conjugate vaccine (adsorbed) - | Injectable suspension | 3386483.1 |
حمّل النسخة الجديدة من تطبيق وزارة الصحة العامة .
للحصول على آخر المستجدات حول فيروس كورونا
ستزوّدك النسخة الجديدة من تطبيق وزارة الصحة العامة بجميع المعلومات الموثوقة حول كوفيد-19، مع تحديثات مستمرة للحالات المؤكدة والبيانات. وإذا كانت لديك أي أعراض، فستكون ميزة “فحص الأعراض” دليلك للمساعدة الذاتية لتقييمها.
